Ticker
MREOCompany Name
MEREO BIOPHARMA GROUP PLCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Free Cash Flow | Free Cash Flow Yield | Market Capitalization |
---|---|---|---|
6/30/2025 | $ -32.94M | -12.47% | $ 264.1M |
3/31/2025 | $ -33.19M | -9% | $ 368.88M |
12/31/2024 | $ -32.83M | -8.71% | $ 376.83M |
9/30/2024 | $ 0 | 0% | $ 636.1M |
6/30/2024 | $ -20.03M | -3.46% | $ 578.49M |
3/31/2024 | $ 0 | 0% | $ 444.66M |
12/31/2023 | $ -21.13M | -5.02% | $ 420.82M |
6/30/2023 | $ -42.02M | -22.84% | $ 183.96M |
12/31/2022 | $ -48.54M | -51.23% | $ 94.74M |
6/30/2022 | $ -43.12M | -41.27% | $ 104.46M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
FCF / Market Cap
(=) FCF Yield
FCF Yield for MEREO BIOPHARMA GROUP PLC is calculated as follows: FCF [ $ -35.45M ] / Market Cap [ $ 228.45M ]
(=) FCF Yield [ -15.52% ]
Minimum
Dec 31, 2022
Maximum
Jun 30, 2024
Average
Median
filtered constituents | 3.58K |
---|---|
min | -33.87% |
max | 37.55% |
average | 1.59% |
median | 3.22% |
std | 11.38% |